Check 35,000+ stocks against 26 valuation models and 37 quality factors

Dentsply Sirona Inc. (0I8F) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of Dentsply Sirona Inc. $4.86, price $8.62, upside -43.6%, quality 51 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

Fair value above price? No
Good quality? Yes
Add to watchlist

Industrials · GB · Home US

DS Some data Sep 24, 2026

Dentsply Sirona Inc.

0I8F · LSE

Stretched ValuationStrong overvaluation with only moderate quality.

!Fair value $4.86 · Strongly overvalued (−43.6%)

!Quality 51/100

!Weak Growth (revenue 5y +1.9 %/yr)

!Loss-making · -17.1% net margin (TTM)

✓Moderate debt · generates free cash flow

✓5.6% dividend yield · Sustainable

!Trails peers (4/13)

!Narrow moat 23/100

!Evidence only medium, so the estimate is less certain

!The models disagree: range $4.26 to $11.01

!Weak on future: 1 out of 100

26 models, one by oneBear $4.26 to bull $11.01 Growth analysisrevenue history, year by year Quality 51/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch Dentsply Sirona Inc. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range $8.62 – $61.74 · fair‑value band $4.26 – $11.01 · the $8.62 price screens above the $4.86 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Dentsply Sirona in your weekly email

Every Wednesday you see whether Dentsply Sirona is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.

Stock analysis

Dentsply Sirona Inc. (0I8F) currently trades at $8.62, while our model-based Fair Value estimate is $4.86, 43.6% below the price, so the stock looks overvalued today.

Valuation

Bull case: the Multiples group reads highest at a median of $11.83 per share, and 4 of the 11 models we run sit above the $8.62 price.

Bear case: the Growth DCF group reads lowest at $1.45, and 7 of the 11 models stay below the price. Evidence for this calculation is medium.

Scenario range: $4.26 (bear) to $11.01 (bull), the price of $8.62 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 51/100 (solid quality), in the Industrials sector.

Weak Growth: Revenue growth is weak: less than 2 % a year.

Dentsply Sirona Inc. reported revenue of $3.7B in FY2025 versus $4.2B in FY2021, a compound −3.4%/yr. Reported net income was −$598M in FY2025.

Key figures

Market cap $1.7B · P/E ratio 0.1 · EPS (TTM) $1.68 · Dividend yield 5.6% · Net margin −16.3% · Return on equity −37.7% · Return on assets (EBIT) 3.8% · Operating margin 3.4%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (medium confidence).

What moves the price

The share trades about 40% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −44% fair-value upside, at −44%, 0I8F screens richer than that median.

Fair Value models

Bear $4.26 Fair Value $4.86 Bull $11.01

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then ($0.9082 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Highest evidence

FCF DCF n/a $1.27 >$5.08 77

Growth DCF n/a $1.45 $5.17 75

5Y EBITDA Exit $8.73 $18.85 $32.25 72

All 11 models by family

DCF Models

FCF DCF n/a $1.27 >$5.08 77

5Y Revenue Exit $0.8000 $5.12 $11.42 65

5Y EBITDA Exit $8.73 $18.85 $32.25 72

10Y Revenue Exit n/a $2.83 $6.20 64

10Y EBITDA Exit $4.70 $11.13 $18.16 66

Multiples

EV/EBIT $7.02 $11.83 $16.64 64

EV/EBITDA $19.04 $27.86 $36.68 67

EV/Revenue $2.89 $7.30 $11.72 50

Asset-Based

NCAV (Graham) $3.01 $4.03 $6.02 54

Growth DCF

Growth DCF n/a $1.45 $5.17 75

Rev-Margin DCF $0.8000 $5.28 $10.71 66

Open the full fair value analysis →

Notify me when 0I8F reaches fair value

Put 0I8F on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 51/100

Of which business quality 47 · Market factors (momentum, volatility) 22

Profitability 22

Margins and returns on capital today

Quality Growth 59

Are margins and returns improving?

Cashflow 25

Earnings quality: real cash, not paper profit

Fin. Strength 25

Balance sheet, leverage, solvency risk

Investment 97

Disciplined investing over empire-building

Low Volatility 50

Calm price path (market factor)

Momentum 17

Price trend over the last 3–12 months (market factor)

52W Momentum 0

Distance to the 52-week high (market factor)

Net Issuance 99

Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 27/100

Revenue growth is weak: less than 2 % a year.

Revenue growth 1 year

−3.0%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

−2.1%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+1.9%

Start year 2020 (pandemic). Over 10 years: +3.2% a year

Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+1.8%

’14

’15

’16

’17

’18

’19

’20

’21

’22

’23

’24

’25

Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.

8.3% (2020) → 6.8% (2025)

What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss

not computed

Growth Forecast

A lot of optimism in the price

The price assumes more growth than the company has delivered so far and more than analysts expect.

What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).

+22.3%

Yearly growth needed for the next five years to justify today's price.

What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.

+1.1%

Yearly sales growth analysts expect, extended to five years.

After inflation (figures in USD, USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +19.5% a year for the price and −1.2% for the forecasts.

Forecast 2026 (sales)−2.6%

Forecast 2027 (sales)+2.1%

Projected 2028 (sales)+2.1%

Projected 2029 (sales)+2.1%

Projected 2030 (sales)+2.1%

0I8F screens overvalued: fair value 44% below the price. Compare with CHEMTECH →

Compare Dentsply Sirona Inc. with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Machinery” was too small, so the broader sector is used.)Industrials · 5328 stocks

Beats the sector median on 4/12 measures

Overall it trails its sector peers.

Valuation

Quality Score 51 · Below median

Fair Value upside −45.3% · Below median

Profitability

Return on assets 2.3% · Below median

Net margin (TTM) −17.1% · Bottom 25%

Operating margin (TTM) 3.4% · Below median

Growth and dividend

Revenue growth 0.1% · Below median

Dividend yield (TTM) 5.6% · Top 25%

Balance sheet

Debt / equity 1.48× · Highest 25%

Valuation Multiplesvs Industrials median · lower = cheaper

P/E (TTM) 0.1× · Cheapest 25%

P/B 1.32× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.

P/S (TTM) 0.48× · Cheaper than median

P/FCF 17.1× · Pricier than median

EV/EBITDA 6.2× · Cheapest 25%

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)0 · sector 17

FUTURE (revenue growth)1 · sector 36

PAST (return on equity)0 · sector 29

HEALTH (low debt)26 · sector 94

DIVIDEND (yield)100 · sector 37

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Machinery stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value
CHEMTECH CHEMTECH	₹59.59	₹33.64	−44%
INLCM INLCM	₹258.90	₹56.93	−78%
Contemporary Amperex Technology Co 300750	¥291.11	¥695.24	+139%
Delta Electronics (Thailand) Public Company DELTA	263.00 THB	38.64 THB	−85%
Larsen & Toubro Limited LT	₹3,876	₹1,994	−49%
Samsung C&T Corporation 028260	367,000 KRW	159,718 KRW	−56%
Adani Ports and Special Economic Zone Limited ADANIPORTS	₹1,738	₹1,041	−40%
Hanwha Aerospace Co 012450	1,021,000 KRW	678,284 KRW	−34%
ASELSAN Elektronik Sanayi ve Ticaret Anonim Sirketi ASELS	372.25 TRY	63.11 TRY	−83%
HD Hyundai Heavy Industries Co 329180	441,000 KRW	485,100 KRW	+10%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Dentsply Sirona Inc. · Fair Value
$4.86 −44%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/0I8F" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">Dentsply Sirona Inc. · Fair Value</span><br><b style="font-size:20px">$4.86</b> <span style="color:#e0816f;font-weight:700;font-size:14px">−44%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "Dentsply Sirona Inc. Fair Value". https://www.fairvalue-calculator.com/stock/0I8F

Frequently asked questions

Is Dentsply Sirona Inc. (0I8F) overvalued or undervalued?

As of Sep 24, 2026, our model estimates a fair value of $4.86 versus a price of $8.62, about −44% upside (overvalued).

What is the fair value of 0I8F?

Our model-based fair value for Dentsply Sirona Inc. is $4.86 (as of Sep 24, 2026), built from audited fundamentals. The current price: $8.62.

What is the quality score of 0I8F?

Dentsply Sirona Inc. has a Quality Score of 51/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for Dentsply Sirona Inc. (0I8F)?

Our model-based price target is the fair value of $4.86 (as of Sep 24, 2026) from 11 valuation models. Cautious scenario $4.26, optimistic scenario $11.01. It is a calculation from audited fundamentals, not an analyst target.

What is the Dentsply Sirona Inc. stock forecast for 2026?

Our models put fair value at $4.86, about −44% upside versus a price of $8.62 (overvalued). Cautious scenario $4.26, optimistic scenario $11.01. The calculation is refreshed regularly with new filings.

What is the revenue of Dentsply Sirona Inc. (0I8F)?

Dentsply Sirona Inc. reported trailing-twelve-month revenue of about $3.7B (latest available figure, as of Sep 24, 2026).

Does Dentsply Sirona Inc. pay a dividend?

Dentsply Sirona Inc. currently shows a dividend yield of about 5.57% relative to its recent price (as of Sep 24, 2026).

What growth is priced into Dentsply Sirona Inc. (0I8F)?

For today's price to be fair in a discounted-cash-flow model, Dentsply Sirona Inc. would have to grow free cash flow by +22.3 % per year for five years (discount rate 10.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +2.0 % per year. As of Sep 24, 2026.

What discount rate (WACC) does the fair value of 0I8F use?

Our models discount Dentsply Sirona Inc. at 10.0 %: a base by market capitalisation (unknown), damped by beta 0.89, country premium for United Kingdom. The same rate applies in all 26 models.

What is a reverse DCF?

A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Dentsply Sirona Inc. that is +22.3 % per year a year over ten years, using the same discount rate (10.0 %) and the same formula as our fair value.

How much growth has Dentsply Sirona Inc. (0I8F) delivered so far?

Over the past 5 years revenue at Dentsply Sirona Inc. grew +2.0 % a year. The price currently implies +22.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.

How fast is the sector of Dentsply Sirona Inc. (0I8F) growing?

The median revenue growth in the sector is +7.2 % a year. That is the yardstick for the growth priced into Dentsply Sirona Inc. (+22.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.

What is the free cash flow yield of Dentsply Sirona Inc. (0I8F)?

The free-cash-flow yield on the price is 4.57 %: that much free cash flow Dentsply Sirona Inc. produces per unit of market value. When it exceeds the discount rate of our models (10.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.

What is the intrinsic value of Dentsply Sirona Inc. (0I8F)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Dentsply Sirona Inc. it is $4.86 per share (as of Sep 24, 2026), against a price of $8.62. It is the blended result of 11 valuation models (cash flow, earnings, asset, dividend).

Is Dentsply Sirona Inc. stock overvalued or undervalued in 2026?

As of Sep 24, 2026, 0I8F trades above its calculated fair value: price $8.62, fair value $4.86, a gap of about −44% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of 0I8F?

No. The price is what the market pays today ($8.62); the fair value is what the company's own numbers justify ($4.86). For Dentsply Sirona Inc. the two are $3.76 per share apart. That gap is exactly why we show both numbers side by side.

How much is Dentsply Sirona Inc. worth?

The market values Dentsply Sirona Inc. at about $1.7B (market capitalisation, as of Sep 24, 2026). Per share that is $8.62; our models calculate a fair value of $4.86 per share.

What do the bullish and bearish scenarios say about 0I8F?

Our models span a range for Dentsply Sirona Inc.: cautious scenario $4.26, base $4.86, optimistic $11.01 per share (as of Sep 24, 2026, price $8.62). The range comes from different growth and margin assumptions, not from analyst opinions.

What is the P/E ratio of 0I8F?

Dentsply Sirona Inc. trades at a price-to-earnings ratio of 0.1 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $4.86 is built from several models across several years. Other multiples: P/B 1.3, P/S 0.5, EV/EBITDA 6.2.

How solid is the balance sheet of Dentsply Sirona Inc. (0I8F)?

Balance-sheet figures for Dentsply Sirona Inc. (as of Sep 24, 2026): return on equity −37.7%, debt of 1.48 per unit of equity. They feed the Quality Score of 51/100, which measures business quality independently of the share price.

How far is 0I8F from its 52-week high?

Dentsply Sirona Inc. trades at $8.62, about 40% below its 52-week high of $14.45 and at the low of $8.62 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of $4.86 is for.

Which stocks are comparable to Dentsply Sirona Inc.?

From the same area (Industrials) we also value CHEMTECH, INLCM, Contemporary Amperex Technology Co, Delta Electronics (Thailand) Public Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is Dentsply Sirona Inc. stock attractive at the current price?

The data as of Sep 24, 2026: price $8.62, calculated fair value $4.86 (−44%), Quality Score 51/100, from 11 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of 0I8F calculated?

We run Dentsply Sirona Inc. through 11 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $4.86, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 14.5 % above its aggregate fair value. Dentsply Sirona Inc. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of Dentsply Sirona Inc. (0I8F)?

The closing price on Oct 2, 2026 was $8.62. Our model-based fair value is $4.86, about −44% upside (overvalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with Dentsply Sirona Inc. right now?

Solid but not exceptional quality (51/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range ($4.26 to $11.01) leaves room in how you read the outcome.

Key figures of Dentsply Sirona Inc.

How large is the market capitalisation of Dentsply Sirona Inc. (0I8F)?

The market capitalisation of Dentsply Sirona Inc. is $1.7B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What are the earnings per share of Dentsply Sirona Inc. (0I8F)?

Earnings per share at Dentsply Sirona Inc. are $1.68 (price ÷ EPS = P/E 0.1). Earnings per share over the last twelve months: total profit spread across every single share.

What is the dividend yield of Dentsply Sirona Inc. (0I8F)?

The dividend yield of Dentsply Sirona Inc. is 5.6% (payout 28.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.

What is the net margin of Dentsply Sirona Inc. (0I8F)?

The net margin of Dentsply Sirona Inc. is −16.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of Dentsply Sirona Inc. (0I8F)?

The return on equity (ROE) of Dentsply Sirona Inc. is −37.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of Dentsply Sirona Inc. (0I8F)?

On an EBIT basis the return on assets of Dentsply Sirona Inc. is 3.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of Dentsply Sirona Inc. (0I8F)?

The operating margin of Dentsply Sirona Inc. is 3.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at Dentsply Sirona Inc. (0I8F)?

Revenue at Dentsply Sirona Inc. is growing +0.1% versus a year earlier (3y avg −2.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How fast are earnings growing at Dentsply Sirona Inc. (0I8F)?

Earnings per share at Dentsply Sirona Inc. are growing +15.2% versus a year earlier. How much earnings per share grew versus a year earlier.

How much net debt does Dentsply Sirona Inc. (0I8F) carry?

The net debt of Dentsply Sirona Inc. is $2.2B (fiscal year 2025, ≈ 21.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.

Free · no account needed

Watch Dentsply Sirona Inc. in the live analysis

One click puts Dentsply Sirona Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.